In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ekos brings in $12.5mm through its Series D round

Executive Summary

Ekos (ultrasound clot dissolver) has raised $12.5mm through its Series D venture round. New and lead investor SaskWorks Venture Fund (formerly Crown Venture Fund) was joined by previous backers Ascension Health Ventures, CID Capital, EGS Healthcare Capital Partners, MedVenture Associates, Mitsui & Co. Venture Partners, NGN Capital, and Protostar Equity Partners.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies